Through the above analysis, we can clearly draw the following conclusions: the expression levels of FOXD1 and EGFR have a very important impact on the survival of patients with head and neck cancer, and abnormally high expression is not conducive to the prognosis of patients. This evidence concerns the gene FOXD1 and head and neck cancer.